<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(3)</volume><submitter>Decool G</submitter><journal>HemaSphere</journal><pagination>e193</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6746024</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.</pubmed_title><pmcid>PMC6746024</pmcid><pubmed_authors>Girard S</pubmed_authors><pubmed_authors>Fenwarth L</pubmed_authors><pubmed_authors>Duployez N</pubmed_authors><pubmed_authors>Grardel N</pubmed_authors><pubmed_authors>Ducourneau B</pubmed_authors><pubmed_authors>Ruminy P</pubmed_authors><pubmed_authors>Decool G</pubmed_authors><pubmed_authors>Domenech C</pubmed_authors><pubmed_authors>Raczkiewicz I</pubmed_authors><pubmed_authors>Preudhomme C</pubmed_authors><pubmed_authors>Bertrand Y</pubmed_authors><pubmed_authors>Plesa A</pubmed_authors><pubmed_authors>Pages MP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy of Tyrosine Kinase Inhibitor Therapy in a Chemotherapy-refractory B-cell Precursor Acute Lymphoblastic Leukemia With ZC3HAV1-ABL2 Fusion.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jun</publication><modification>2025-04-22T17:35:54.46Z</modification><creation>2025-04-06T02:06:53.978Z</creation></dates><accession>S-EPMC6746024</accession><cross_references><pubmed>31723830</pubmed><doi>10.1097/HS9.0000000000000193</doi></cross_references></HashMap>